Canton Strategic Holdings, Inc.

CNTN

Healthcare Biotechnology

EPS
+85.9%
Free cash flow
−600.4%

Quarter to June 2026, against a year earlier

2.06 0.13 +6.74%
Market cap
$164.1M
P/E
n/m
Fwd P/E
—
Dividend yield
—
F-score
n/a
ROIC
−8.11%
Net debt / EBITDA
0.8×
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
ROE
(43.10%) (34.42%) (17.99%) (225.01%)

+8 more TTM periods

ROA
(34.60%) (27.53%) (13.74%) (159.36%)
ROIC
(8.11%) (7.94%) (3.26%) 0.00%
Return on Tangible Assets
(254.25%) (192.44%) (254.73%) (167.66%)
Free Cash Flow per Share
(0.10) (0.10) (0.50) (1.40)
Free Cash Flow
(22.17) (21.07) (16.13) (8.72)
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026